G protein-coupled receptors: structure- and function-based drug discovery

被引：0

作者：

Dehua Yang

Qingtong Zhou

Viktorija Labroska

Shanshan Qin

Sanaz Darbalaei

Yiran Wu

Elita Yuliantie

Linshan Xie

Houchao Tao

Jianjun Cheng

Qing Liu

Suwen Zhao

Wenqing Shui

Yi Jiang

Ming-Wei Wang

机构：

[1] Chinese Academy of Sciences,The National Center for Drug Screening, Shanghai Institute of Materia Medica

[2] Chinese Academy of Sciences,The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica

[3] Fudan University,School of Basic Medical Sciences

[4] University of Chinese Academy of Sciences,iHuman Institute

[5] ShanghaiTech University,School of Life Science and Technology

[6] ShanghaiTech University,School of Pharmacy

[7] Fudan University,undefined

来源：

Signal Transduction and Targeted Therapy | / 6卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

As one of the most successful therapeutic target families, G protein-coupled receptors (GPCRs) have experienced a transformation from random ligand screening to knowledge-driven drug design. We are eye-witnessing tremendous progresses made recently in the understanding of their structure–function relationships that facilitated drug development at an unprecedented pace. This article intends to provide a comprehensive overview of this important field to a broader readership that shares some common interests in drug discovery.

引用

共 50 条

[31] Erratum: Structural diversity of G protein-coupled receptors and significance for drug discovery
Malin C. Lagerström
Helgi B. Schiöth
Nature Reviews Drug Discovery, 2008, 7 : 542 - 542
[32] The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery
Robertson, Nathan
Jazayeri, Ali
Errey, James
Baig, Asma
Hurrell, Edward
Zhukov, Andrei
Langmead, Christopher J.
Weir, Malcolm
Marshall, Fiona H.
NEUROPHARMACOLOGY, 2011, 60 (01) : 36 - 44
[33] G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery
Zhang, Mingyang
Chen, Ting
Lu, Xun
Lan, Xiaobing
Chen, Ziqiang
Lu, Shaoyong
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
[34] Drug efficacy at G protein-coupled receptors
Kenakin, T
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 : 349 - 379
[35] Fragment screening and structure-based drug design with G protein-coupled receptors
Andrews, Steve P.
Therapeutics, Heptares
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[36] Computational Modeling of Structure-Function of G Protein-Coupled Receptors with Applications for Drug Design
Li, Y. Y.
Hou, T. J.
Goddard, W. A., III
CURRENT MEDICINAL CHEMISTRY, 2010, 17 (12) : 1167 - 1180
[37] Sphingolipids in the function of G protein-coupled receptors
Jafurulla, Mohammad
Chattopadhyay, Amitabha
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 763 : 241 - 246
[38] G Protein-Coupled Receptors: A Century of Research and Discovery
Liu, Samuel
Anderson, Preston J.
Rajagopal, Sudarshan
Lefkowitz, Robert J.
Rockman, Howard A.
CIRCULATION RESEARCH, 2024, 135 (01) : 174 - 197
[39] Continued discovery of ligands for G protein-coupled receptors
Lee, DK
George, SR
O'Dowd, BF
LIFE SCIENCES, 2003, 74 (2-3) : 293 - 297
[40] Allosteric modulators of G protein-coupled receptors: From structure to function
Christopoulos, Arthur
ENDOCRINE JOURNAL, 2010, 57 : S303 - S303

← 1 2 3 4 5 →